Article
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML
25 Nov 2019
Abstract excerpt
An understanding of natural killer (NK) cell physiology in acute myeloid leukemia (AML) has led to the use of NK cell transfer in patients, demonstrating promising clinical results. However, AML is still characterized by a high relapse rate and poor overall survival. In addition to conventional NKs that can be considered the innate counterparts of CD8 T cells, another family of innate lymphocytes has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
